Multidrug transporters as drug targets

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• Drug transport molecules significantly influence pharmacodynamics and pharmacokinetics.
• P-glycoprotein (Pgp), multidrug resistance protein 1 (MRP1), and MRP2 are key transporters affecting drug distribution.
• These transporters are often targets in drug development and therapy.

Purpose of the Study:

• To review the role of Pgp, MRP1, and MRP2 in drug transport.
• To discuss the implications of targeting these transporters in drug therapy, particularly in cancer chemotherapy.
• To highlight the challenges and potential of developing specific inhibitors for these molecules.

Main Methods:

• Literature review of studies on drug transporters and their substrates.
• Analysis of the expression patterns and functions of Pgp, MRP1, and MRP2.
• Examination of existing and potential therapeutic strategies involving transporter modulation.

Main Results:

• Pgp is a major transporter affecting drug distribution at various organ sites.
• MRP1 and MRP2 also contribute to drug transport, with MRP1 playing a protective role.
• Most Pgp inhibitors show low affinity for MRP1 and MRP2, indicating a need for specific inhibitors.
• Targeting these transporters can influence drug pharmacokinetics and efficacy, especially in cancer treatment.

Conclusions:

• Drug transporters, particularly Pgp, are critical determinants of drug behavior in the body.
• Modulating transporter activity offers a promising strategy for enhancing drug efficacy and overcoming resistance.
• Further research into specific and effective inhibitors for MRP1 and MRP2 is warranted.